1. Home
  2. SLDB vs GHM Comparison

SLDB vs GHM Comparison

Compare SLDB & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$9.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Graham Corporation

GHM

Graham Corporation

HOLD

Current Price

$109.76

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
GHM
Founded
2013
1936
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
SLDB
GHM
Price
$9.55
$109.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$16.36
$73.33
AVG Volume (30 Days)
2.6M
225.6K
Earning Date
05-12-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
0.90
EPS
N/A
1.12
Revenue
$8,094,000.00
$245,293,000.00
Revenue This Year
N/A
$14.54
Revenue Next Year
N/A
$18.23
P/E Ratio
N/A
$95.84
Revenue Growth
N/A
16.86
52 Week Low
$3.79
$46.08
52 Week High
$11.45
$125.82

Technical Indicators

Market Signals
Indicator
SLDB
GHM
Relative Strength Index (RSI) 54.10 51.54
Support Level $6.38 $88.46
Resistance Level $11.45 $125.82
Average True Range (ATR) 0.68 5.16
MACD -0.12 -1.54
Stochastic Oscillator 32.02 33.52

Price Performance

Historical Comparison
SLDB
GHM

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About GHM Graham Corporation

Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.

Share on Social Networks: